Lauren Riker
CIK 1545439 · View on SEC EDGAR ↗
First SEC filing: June 5, 2026 · Latest: June 5, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 11, 2026 | PCRX | S 10b5-1 | 6,115 | $23.50 | $143,702 | 62,284 Direct | -8.94% | Disposed | 2.1% (price as of 2026-08-21) |
| June 4, 2025 | PCRX | S | 5,578 | $26.21 | $146,199 | 59,564 Direct | -8.56% | Disposed | -8.5% (price as of 2026-08-21) |
| June 12, 2024 | PCRX | S 10b5-1 | 3,970 | $28.72 | $114,018 | 38,075 Direct | -9.44% | Disposed | -16.5% (price as of 2026-08-21) |
| July 5, 2023 | PCRX | S 10b5-1 | 643 | $38.91 | $25,019 | 22,687 Direct | -2.76% | Disposed | -38.3% (price as of 2026-08-21) |
| June 14, 2023 | PCRX | S 10b5-1 | 7 | $39.01 | $273 | 22,687 Direct | -0.03% | Disposed | -38.5% (price as of 2026-08-21) |
| June 14, 2023 | PCRX | S 10b5-1 | 5,773 | $38.52 | $222,376 | 22,694 Direct | -20.28% | Disposed | -37.7% (price as of 2026-08-21) |
| June 14, 2023 | PCRX | S 10b5-1 | 586 | $37.47 | $21,957 | 28,467 Direct | -2.02% | Disposed | -36.0% (price as of 2026-08-21) |
| June 7, 2023 | PCRX | S | 616 | $37.86 | $23,322 | 19,053 Direct | -3.13% | Disposed | -36.6% (price as of 2026-08-21) |
| June 6, 2023 | PCRX | S | 591 | $38.99 | $23,043 | 19,669 Direct | -2.92% | Disposed | -38.5% (price as of 2026-08-21) |
| June 6, 2022 | PCRX | S | 1,150 | $61.37 | $70,576 | 14,002 Direct | -7.59% | Disposed | -60.9% (price as of 2026-08-21) |
| March 10, 2022 | PCRX | S | 900 | $71.95 | $64,755 | 15,152 Direct | -5.61% | Disposed | -66.7% (price as of 2026-08-21) |
| March 10, 2022 | PCRX | S | 8,400 | $71.14 | $597,576 | 16,052 Direct | -34.35% | Disposed | -66.3% (price as of 2026-08-21) |
| Jan. 18, 2022 | PCRX | S 10b5-1 | 2,500 | $64.97 | $162,425 | 15,152 Direct | -14.16% | Disposed | -63.1% (price as of 2026-08-21) |
| July 29, 2021 | PCRX | S 10b5-1 | 90 | $60.81 | $5,473 | 13,152 Direct | -0.68% | Disposed | -60.5% (price as of 2026-08-21) |
| July 28, 2021 | PCRX | S 10b5-1 | 2,410 | $60.85 | $146,648 | 13,152 Direct | -15.49% | Disposed | -60.6% (price as of 2026-08-21) |
| June 11, 2021 | PCRX | S | 2,003 | $59.85 | $119,880 | 12,731 Direct | -13.59% | Disposed | -59.9% (price as of 2026-08-21) |
| June 4, 2021 | PCRX | S | 1,047 | $61.04 | $63,909 | 12,134 Direct | -7.94% | Disposed | -60.7% (price as of 2026-08-21) |
| March 17, 2021 | PCRX | S | 2,000 | $70.01 | $140,020 | 13,181 Direct | -13.17% | Disposed | -65.7% (price as of 2026-08-21) |
| March 15, 2021 | PCRX | S | 1,520 | $73.28 | $111,386 | 13,181 Direct | -10.34% | Disposed | -67.3% (price as of 2026-08-21) |
| Nov. 13, 2020 | PCRX | S 10b5-1 | 3,000 | $63.81 | $191,430 | 13,181 Direct | -18.54% | Disposed | -62.4% (price as of 2026-08-21) |
| Sept. 16, 2020 | PCRX | S 10b5-1 | 3,000 | $60.34 | $181,020 | 13,181 Direct | -18.54% | Disposed | -60.2% (price as of 2026-08-21) |
| Aug. 11, 2020 | PCRX | S | 8,180 | $60.50 | $494,890 | 13,181 Direct | -38.29% | Disposed | -60.3% (price as of 2026-08-21) |
| June 29, 2020 | PCRX | S 10b5-1 | 2,000 | $50.34 | $100,680 | 12,633 Direct | -13.67% | Disposed | -52.3% (price as of 2026-08-21) |
| June 29, 2020 | PCRX | S 10b5-1 | 2,000 | $49.34 | $98,680 | 14,633 Direct | -12.02% | Disposed | -51.4% (price as of 2026-08-21) |
| June 29, 2020 | PCRX | S 10b5-1 | 2,000 | $48.72 | $97,440 | 16,633 Direct | -10.73% | Disposed | -50.8% (price as of 2026-08-21) |
| June 5, 2020 | PCRX | S | 1,752 | $48.37 | $84,744 | 7,833 Direct | -18.28% | Disposed | -50.4% (price as of 2026-08-21) |
| June 4, 2020 | PCRX | S | 879 | $46.33 | $40,724 | 9,585 Direct | -8.40% | Disposed | -48.2% (price as of 2026-08-21) |
| May 21, 2020 | PCRX | S | 2,000 | $45.26 | $90,520 | 10,464 Direct | -16.05% | Disposed | -47.0% (price as of 2026-08-21) |
| May 19, 2020 | PCRX | S | 2,000 | $42.81 | $85,620 | 10,464 Direct | -16.05% | Disposed | -44.0% (price as of 2026-08-21) |
| Feb. 10, 2020 | PCRX | S 10b5-1 | 1,000 | $49.81 | $49,810 | 10,464 Direct | -8.72% | Disposed | -51.8% (price as of 2026-08-21) |
| Feb. 10, 2020 | PCRX | S 10b5-1 | 1,000 | $48.81 | $48,810 | 11,464 Direct | -8.02% | Disposed | -50.9% (price as of 2026-08-21) |
| Feb. 10, 2020 | PCRX | S 10b5-1 | 1,000 | $47.81 | $47,810 | 12,464 Direct | -7.43% | Disposed | -49.8% (price as of 2026-08-21) |
| Feb. 7, 2020 | PCRX | S 10b5-1 | 170 | $46.81 | $7,958 | 10,464 Direct | -1.60% | Disposed | -48.8% (price as of 2026-08-21) |
| Feb. 6, 2020 | PCRX | S 10b5-1 | 830 | $46.81 | $38,852 | 10,464 Direct | -7.35% | Disposed | -48.8% (price as of 2026-08-21) |
| Dec. 23, 2019 | PCRX | S 10b5-1 | 1,000 | $45.92 | $45,920 | 10,464 Direct | -8.72% | Disposed | -47.8% (price as of 2026-08-21) |
| Nov. 20, 2019 | PCRX | S | 1,176 | $44.14 | $51,909 | 10,464 Direct | -10.10% | Disposed | -45.7% (price as of 2026-08-21) |
| Nov. 11, 2019 | PCRX | S | 5,000 | $43.59 | $217,950 | 10,640 Direct | -31.97% | Disposed | -45.0% (price as of 2026-08-21) |
| June 10, 2019 | PCRX | S | 2,126 | $44.28 | $94,139 | 10,042 Direct | -17.47% | Disposed | -45.8% (price as of 2026-08-21) |
| June 4, 2019 | PCRX | S | 967 | $42.91 | $41,494 | 10,268 Direct | -8.61% | Disposed | -44.1% (price as of 2026-08-21) |
| Nov. 2, 2018 | PCRX | S 10b5-1 | 1,000 | $54.35 | $54,350 | 10,474 Direct | -8.72% | Disposed | -55.9% (price as of 2026-08-21) |
Showing latest 100 of 127 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 14, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (25,000) | $38.74 | June 14, 2033 | 25,000 | Acquired |
| June 8, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (14,600) | $59.39 | June 8, 2032 | 14,600 | Acquired |
| March 10, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (9,300) | $10.81 | June 5, 2022 | 9,300 | Disposed |
| Jan. 18, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (2,500) | $10.81 | June 5, 2022 | 2,500 | Disposed |
| Jan. 4, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (5,000) | $61.60 | Jan. 4, 2032 | 5,000 | Acquired |
| July 29, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (90) | $10.81 | June 5, 2022 | 90 | Disposed |
| July 28, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (2,410) | $10.81 | June 5, 2022 | 2,410 | Disposed |
| June 9, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (6,500) | $60.96 | June 9, 2031 | 6,500 | Acquired |
| March 17, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (2,000) | $10.81 | June 5, 2022 | 2,000 | Disposed |
| March 15, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (1,520) | $10.81 | June 5, 2022 | 1,520 | Disposed |
| Nov. 13, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (3,000) | $10.81 | June 5, 2022 | 3,000 | Disposed |
| Sept. 16, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (3,000) | $10.81 | June 5, 2022 | 3,000 | Disposed |
| Aug. 11, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (8,180) | $10.34 | May 10, 2021 | 8,180 | Disposed |
| June 29, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (6,000) | $10.34 | May 10, 2021 | 6,000 | Disposed |
| June 9, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (12,000) | $47.65 | June 9, 2030 | 12,000 | Acquired |
| May 21, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (2,000) | $10.34 | May 10, 2021 | 2,000 | Disposed |
| May 19, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (2,000) | $10.34 | May 10, 2021 | 2,000 | Disposed |
| Feb. 10, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (3,000) | $10.81 | June 5, 2022 | 3,000 | Disposed |
| Feb. 7, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (170) | $10.81 | June 5, 2022 | 170 | Disposed |
| Feb. 6, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (830) | $10.81 | June 5, 2022 | 830 | Disposed |
| Dec. 23, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (1,000) | $10.81 | June 5, 2022 | 1,000 | Disposed |
| Nov. 20, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (1,000) | $10.81 | June 5, 2022 | 1,000 | Disposed |
| Nov. 11, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (180) | $10.81 | June 5, 2022 | 180 | Disposed |
| Nov. 11, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (4,820) | $10.34 | May 10, 2021 | 4,820 | Disposed |
| June 5, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (11,200) | $43.54 | June 5, 2029 | 11,200 | Acquired |
| Nov. 2, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (1,000) | $10.34 | May 10, 2021 | 1,000 | Disposed |
| Sept. 24, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (1,000) | $10.34 | May 10, 2021 | 1,000 | Disposed |
| June 13, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (25,000) | $38.35 | June 13, 2028 | 25,000 | Acquired |
| June 14, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (6,000) | $44.20 | June 14, 2027 | 6,000 | Acquired |
| Dec. 7, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (6,000) | $32.35 | Dec. 7, 2026 | 6,000 | Acquired |
| June 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (6,250) | $40.34 | June 15, 2026 | 6,250 | Acquired |
| June 3, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (7,500) | $79.43 | June 3, 2025 | 7,500 | Acquired |
| March 16, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (5,000) | $10.34 | May 10, 2021 | 5,000 | Disposed |
| June 3, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock (15,000) | $81.00 | June 3, 2024 | 15,000 | Acquired |
| March 14, 2013 | PCRX | Employee Stock Option (right to buy) | Common Stock (10,000) | $10.34 | May 10, 2021 | 10,000 | Disposed |
| June 5, 2012 | PCRX | Common Stock | Common Stock (30,000) | $10.81 | June 4, 2022 | 30,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2013 | $218,437 | $70,000 | — | — | — | — | $378 | $288,815 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.